期刊文献+

多普勒超声对尿毒症患者左心室舒张功能的评价 被引量:1

Evaluation of the left ventricular diastolic function in patients with uremia by using Doppler ultrasound
原文传递
导出
摘要 目的探讨应用脉冲及频谱多普勒超声评价尿毒症患者的不同心室构型左心室舒张功能的状况,为评价其心室的舒张功能提供超声依据。方法选择尿毒症患者36例,根据不同的左心室构型分为A(左心室构型正常组)、B(左心室离心性肥厚组)、C(左心室向心性肥厚组)三组。评价左心室舒张功能,应用多普勒技术,测量左心室舒张功能参数并进行分析。结果 B组的E/A和e'值较A组显著降低(P <0. 01),C组的E/A和e'值较A组亦显著降低(P <0. 01); C组的E/e'比值较B组呈显著增高趋势(P <0. 01)。结论左心室向心性肥厚和离心性肥厚构型的左心室舒张功能均较正常降低,尤以向心性肥厚减低更为明显。 Objective To study the left ventricular diastolic function in different ventricular configurations in patients with uremia by pulse and spectral Doppler ultrasound, and to provide the basis for evaluating the degree of left ventricular diastolic dysfunction. Methods According to left ventricular configuration, a total of 36 patients with uremia were divided into A group (normal group), B group (eccentric hypertrophy group) and C group (concentric hypertrophy group). LV diastolic function parameters were measured by Doppler and analyzed. Results Compared with A group, the values of E/A and e' decreased significantly in both B and C group(P 〈0. 01 ). E/e' of the patients of C group were significantly increased than those of B group (P 〈 0. 01 ). Conclusion The left ventricular diastolic function of patients with ventricular geometry of eccentric hypertrophy and concentric hypertrophy is poor, especilly the later one.
作者 梁虹 LIANG Hong(Department of Ultrasound,Zhongguancun Hospital of Beijing,Beijing 100190,China)
出处 《哈尔滨医科大学学报》 CAS 2018年第3期286-288,共3页 Journal of Harbin Medical University
关键词 多普勒超声 尿毒症 左心室舒张功能 心室构型 doppler uremia left ventricular diastolic function ventricular geometry
  • 相关文献

参考文献5

二级参考文献62

  • 1李真真,王志斌,孙品,聂晶,李艳,付秀秀,张金慧.二维应变成像技术评价左心室构型正常高血压患者的心肌功能[J].中华医学超声杂志(电子版),2013,10(1):52-58. 被引量:7
  • 2郭安民,杜威宇,邝慧瑜,何淑媚,张曲涛,李杰,黄季春.肾移植前后左心功能对比分析及评价[J].中国现代医学杂志,2004,14(17):110-111. 被引量:4
  • 3Semple D, Smith K, Bhandari S, et al lin resistance:a critical role for AKT (2) :207 -215.
  • 4Uremic cardiomyopathy and insu- [ J ]. I Am Soc Nephrol, 2011,22.
  • 5Peterson GE, de Backer T, Contreras G, et al. Relationship of left ven- tricular hypertrophy and diastolic function with cardiovascular and renal outcomes in african americans with hypertensive chronic kidney disease [ J]. Hypertension,2013,62 (3) :518 - 525.
  • 6Ohsawa M, Tamura T, Wakui H, et al. Addition of aliskiren to angotensin receptor blocker improves ambulatory blood pressure profile and cardio- renal function better than addition of benazepril in chronic kidney dis- ease[J]. Int J Mol Sci,2013,14(8) :15361 - 15375.
  • 7Sprague SM, Moe SM. The case for routine parathyroid hormone monito- ring[J]. Clin J Am Soc Nephrol,2013,8(2) :313 -318.
  • 8Siedlecki AM, Jin X, Muslin AJ. Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin [ J]. Hyperten- sion,2009,54(6) :1313 - 1320.
  • 9Kennedy D J, Elkareh J, Shidyak A, et al. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse [ J ]. Am J Physiol Renal Physi- ol,2008,294(2) :450 -454.
  • 10Chen YT, Cheng BC, Ko SF, et al. Value and level of circulating endo- thelial progenitor cells,angiogenesis factord and mononuclear cell apop- tosis in patients with chronic kidney disease [ J ]. Clin Exp Nephrol, 2013,17(1) :83 -91.

共引文献48

同被引文献10

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部